These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17989717)

  • 21. Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia.
    Saleh LM; Wang W; Herman SE; Saba NS; Anastas V; Barber E; Corrigan-Cummins M; Farooqui M; Sun C; Sarasua SM; Zhao Z; Abousamra NK; Elbaz O; Abdelghaffar HA; Wiestner A; Calvo KR
    Leukemia; 2017 Feb; 31(2):340-349. PubMed ID: 27431016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target identification of microRNAs expressed highly in human embryonic stem cells.
    Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
    J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
    Tavolaro S; Colombo T; Chiaretti S; Peragine N; Fulci V; Ricciardi MR; Messina M; Bonina S; Brugnoletti F; Marinelli M; Di Maio V; Mauro FR; Del Giudice I; Macino G; Foà R; Guarini A
    Genes Chromosomes Cancer; 2015 Apr; 54(4):222-34. PubMed ID: 25645730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia.
    Srivastava S; Tsongalis GJ; Kaur P
    Clin Biochem; 2016 Nov; 49(16-17):1307-1310. PubMed ID: 27544753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia.
    Lionetti M; Musto P; Di Martino MT; Fabris S; Agnelli L; Todoerti K; Tuana G; Mosca L; Gallo Cantafio ME; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omede' P; Morabito F; Tassone P; Boccadoro M; Palumbo A; Neri A
    Clin Cancer Res; 2013 Jun; 19(12):3130-42. PubMed ID: 23613318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
    Agirre X; Jiménez-Velasco A; San José-Enériz E; Garate L; Bandrés E; Cordeu L; Aparicio O; Saez B; Navarro G; Vilas-Zornoza A; Pérez-Roger I; García-Foncillas J; Torres A; Heiniger A; Calasanz MJ; Fortes P; Román-Gómez J; Prósper F
    Mol Cancer Res; 2008 Dec; 6(12):1830-40. PubMed ID: 19074828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.
    De Cecco L; Capaia M; Zupo S; Cutrona G; Matis S; Brizzolara A; Orengo AM; Croce M; Marchesi E; Ferrarini M; Canevari S; Ferrini S
    PLoS One; 2015; 10(8):e0134706. PubMed ID: 26305332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
    Pallasch CP; Patz M; Park YJ; Hagist S; Eggle D; Claus R; Debey-Pascher S; Schulz A; Frenzel LP; Claasen J; Kutsch N; Krause G; Mayr C; Rosenwald A; Plass C; Schultze JL; Hallek M; Wendtner CM
    Blood; 2009 Oct; 114(15):3255-64. PubMed ID: 19692702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).
    Hanlon K; Rudin CE; Harries LW
    PLoS One; 2009 Sep; 4(9):e7169. PubMed ID: 19779621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological analysis of chronic lymphocytic leukemia: integration of mRNA and microRNA expression profiles.
    Dong L; Bi KH; Huang N; Chen CY
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of microRNAs in chronic lymphocytic leukemia (Review).
    Zhou XX; Wang X
    Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of signaling pathways and miRNAs in chronic lymphocytic leukemia.
    Li PP; Wang X
    Chin Med J (Engl); 2013 Nov; 126(21):4175-82. PubMed ID: 24229693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.
    Wang LQ; Liang R; Chim CS
    Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia.
    Humplikova L; Kollinerova S; Papajik T; Pikalova Z; Holzerova M; Prochazka V; Divoka M; Modriansky M; Indrak K; Jarosova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):284-93. PubMed ID: 24026141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
    Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
    Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.
    Rodríguez-Vicente AE; Quwaider D; Benito R; Misiewicz-Krzeminska I; Hernández-Sánchez M; de Coca AG; Fisac R; Alonso JM; Zato C; de Paz JF; García JL; Sarasquete ME; Hernández JÁ; Corchado JM; González M; Gutiérrez NC; Hernández-Rivas JM
    BMC Cancer; 2015 Apr; 15():238. PubMed ID: 25880332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.
    Hernández-Sánchez M; Rodríguez-Vicente AE; Hernández JÁ; Lumbreras E; Sarasquete ME; Martín AÁ; Benito R; Vicente-Gutiérrez C; Robledo C; Heras Nde L; Rodríguez JN; Alcoceba M; Coca AG; Aguilar C; González M; Hernández-Rivas JM
    Leuk Res; 2016 Jul; 46():30-6. PubMed ID: 27111859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variants in miRNA processing genes and pre-miRNAs are associated with the risk of chronic lymphocytic leukemia.
    Martin-Guerrero I; Gutierrez-Camino A; Lopez-Lopez E; Bilbao-Aldaiturriaga N; Pombar-Gomez M; Ardanaz M; Garcia-Orad A
    PLoS One; 2015; 10(3):e0118905. PubMed ID: 25793711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.